Photo of Hagop Kantarjian from mdanderson.org
Nov 6, 2023, 03:36
Hagop Kantarjian: Inotuzumab is safe and effective for the eradication of MRD in patients with B-cell ALL, with a MRD negativity rate of 69%
Hagop Kantarjian, Chair of MD Anderson Cancer Center, shared a post on Twitter:
Inotuzumab is safe and effective for the eradication of MRD in patients with B-cell ALL, with a MRD negativity rate of 69%.
Elias Jabbour, Fadi Haddad, Hagop Kantarjian of MD Anderson Cancer Center.
Elias Jabbour, Fadi Haddad, Hagop Kantarjian of MD Anderson Cancer Center.
For the article click here.
Source: Hagop Kantarjian/Twitter
Aug 15, 2024, 13:20